Radiofrequency Ablation vs Stereotactic Body Radiotherapy for Recurrent HCC
1. Local progression-free survival at 3 years was 84.3% in the SBRT group vs 67.3% in the RFA group, with ...
1. Local progression-free survival at 3 years was 84.3% in the SBRT group vs 67.3% in the RFA group, with ...
1. The median progression-free survival in the metastasis-directed therapy arm was 10.3 months vs 2.5 months in the control arm ...
1. Median progression-free survival was greater in the SBRT group than in the standard-of-care group. 2. Patients with NSCLC displayed ...
1. Median progression-free survival was greater in the SBRT group than in the standard-of-care group. 2. Patients with NSCLC displayed ...
1. Stereotactic body radiotherapy in addition to immune checkpoint inhibitors has similar progression-free survival to immune checkpoint inhibitors alone, with ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.